Superstring Capital Management’s Marinus Pharmaceuticals MRNS Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNS
Superstring Capital Management's MRNS Position: Q3 2024 in Review
Superstring Capital Management sold out of Marinus Pharmaceuticals (MRNS) in Q3 2024, closing a stake of 261,861 shares — an estimated $306K sold.
Superstring Capital Management first reported a position in MRNS in Q4 2023 and held it in 3 quarters. The position peaked at $5.11M in Q1 2024. 75 funds tracked by Wall St. Rank hold MRNS as of Q3 2024.
- Superstring Capital Management reported no remaining Marinus Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
- Superstring Capital Management sold 261,861 Marinus Pharmaceuticals shares in Q3 2024, an estimated $306K.
- Superstring Capital Management first reported a position in Marinus Pharmaceuticals in Q4 2023 and held it in 3 quarters.
- Superstring Capital Management's Marinus Pharmaceuticals position peaked at $5.11M in Q1 2024.
- 75 funds tracked by Wall St. Rank held Marinus Pharmaceuticals as of Q3 2024.
Based on Superstring Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.